Literature DB >> 15597324

Predominant role of IgM-dependent activation of the classical pathway in the clearance of dying cells by murine bone marrow-derived macrophages in vitro.

Pierre Quartier1, Paul K Potter, Michael R Ehrenstein, Mark J Walport, Marina Botto.   

Abstract

Soluble molecules including complement components have been shown to facilitate the clearance of dying cells by phagocytes, a process that is important in preventing tissue damage and autoimmunity. However, the extent to which complement is involved in this process and the relative contribution of each of the complement activation pathways is not fully understood. We examined the role of complement in the recognition/uptake of apoptotic thymocytes by murine bone marrow-derived macrophages (BMDM) in vitro using sera from gene-targeted mice. We found this process to be IgM- and complement-dependent, especially when the apoptotic cell-to-BMDM ratio was low, and the level of C3 deposition on apoptotic cells correlated closely with their uptake. The addition of C1q rectified the phagocytic defect seen in the presence of C1q-deficient serum in vitro but had no effect on the phagocytic defect observed with serum deficient in both IgM antibodies and C1q. Similarly, complement activation by IgM antibodies was essential for in vivo C3 deposition on apoptotic cells and their uptake by peritoneal macrophages. Hence, the efficient uptake of dying cells by BMDM requires IgM antibodies and complement.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15597324     DOI: 10.1002/eji.200425497

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  60 in total

Review 1.  Natural IgM in immune equilibrium and harnessing their therapeutic potential.

Authors:  Srini V Kaveri; Gregg J Silverman; Jagadeesh Bayry
Journal:  J Immunol       Date:  2012-02-01       Impact factor: 5.422

Review 2.  The importance of natural IgM: scavenger, protector and regulator.

Authors:  Michael R Ehrenstein; Clare A Notley
Journal:  Nat Rev Immunol       Date:  2010-10-15       Impact factor: 53.106

3.  A Novel Mechanism for Generating the Interferon Signature in Lupus: Opsonization of Dead Cells by Complement and IgM.

Authors:  Haoyang Zhuang; Shuhong Han; Yi Li; Deborah Kienhöfer; Pui Lee; Stepan Shumyak; Richard Meyerholz; Krzysztof Rosadzinski; Danielle Rosner; Annie Chan; Yuan Xu; Mark Segal; Eric Sobel; Li-Jun Yang; Markus H Hoffmann; Westley H Reeves
Journal:  Arthritis Rheumatol       Date:  2016-12       Impact factor: 10.995

4.  Regulation of dendritic cells and macrophages by an anti-apoptotic cell natural antibody that suppresses TLR responses and inhibits inflammatory arthritis.

Authors:  Yifang Chen; Sahil Khanna; Carl S Goodyear; Yong Beom Park; Eyal Raz; Steffen Thiel; Caroline Grönwall; Jaya Vas; David L Boyle; Maripat Corr; Dwight H Kono; Gregg J Silverman
Journal:  J Immunol       Date:  2009-06-29       Impact factor: 5.422

5.  A revival for immunoglobulin therapy in septic shock?

Authors:  Julien Textoris; Thierry Calandra; Frédéric Pène
Journal:  Intensive Care Med       Date:  2014-10-30       Impact factor: 17.440

6.  SIGN-R1, a C-type lectin, enhances apoptotic cell clearance through the complement deposition pathway by interacting with C1q in the spleen.

Authors:  M G Prabagar; Y Do; S Ryu; J-Y Park; H-J Choi; W-S Choi; T J Yun; J Moon; I-S Choi; K Ko; K Ko; C Young Shin; C Cheong; Y-S Kang
Journal:  Cell Death Differ       Date:  2012-12-14       Impact factor: 15.828

7.  MAPK phosphatase-1 is required for regulatory natural autoantibody-mediated inhibition of TLR responses.

Authors:  Caroline Grönwall; Yifang Chen; Jaya Vas; Sahil Khanna; Steffen Thiel; Maripat Corr; Dwight H Kono; Gregg J Silverman
Journal:  Proc Natl Acad Sci U S A       Date:  2012-11-08       Impact factor: 11.205

8.  Murine low-density lipoprotein receptor-related protein 1 (LRP) is required for phagocytosis of targets bearing LRP ligands but is not required for C1q-triggered enhancement of phagocytosis.

Authors:  Anna P Lillis; Mallary C Greenlee; Irina Mikhailenko; Salvatore V Pizzo; Andrea J Tenner; Dudley K Strickland; Suzanne S Bohlson
Journal:  J Immunol       Date:  2008-07-01       Impact factor: 5.422

Review 9.  Antibody-initiated beneficial and harmful immune responses.

Authors:  Arpad Zsigmond Barabas; Chad Douglas Cole; Rene Lafreniere
Journal:  Immunol Res       Date:  2018-12       Impact factor: 2.829

10.  Tolerance, loss of tolerance and regaining tolerance to self by immune-mediated events.

Authors:  Arpad Zsigmond Barabas; Chad Douglas Cole; Richard Milton Graeff; Rene Lafreniere; Donald Mackay Weir
Journal:  Immunol Res       Date:  2017-02       Impact factor: 2.829

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.